A rigid anilido bipyridyl ligand has been designed for use in an organoscandium‐based carbon dioxide hydrosilation catalyst. Ligand attachment by alkane elimination results in metalation of an aryl CH bond in a 3,5‐di‐ tert ‐butylphenyl group installed on the pyridyl unit, thus rendering the ligand tetradentate. Insertion of CO 2 into the newly formed ScC bond leads to a κ 1 carboxylate which, when treated with the borane B(C 6 F 5 ) 3 , becomes hemilabile. In addition to activating the catalyst, the k 1 carboxylate effectively sequesters free B(C 6 F 5 ) 3 and the ensemble is able to effectively hydrosilate CO 2 , in the presence of excess Et 3 SiH, almost exclusively to R 3 SiOCH 2 OSiR 3 . A maximum turnover number of about 3400 (conversion of silane) is observed. Mechanistic experiments suggest that the sequestration of free B(C 6 F 5 ) 3 by the hemilabile carboxylate contributes to the selectivity observed and prevents over reduction to methane.
No takes yet. Share an insight, caveat, or question.
LeBlanc et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: